Patent US5028611A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5028611A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment for cocaine use

Assignee: University of Minnesota System
•
Filing: 1989-06-29
•
Granted: 1991-07-02
•
Expires: 2009-06-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The craving for cocaine and use of cocaine among users may be reduced by administration of carbamazepine. Cocaine-usage is effectively treated with the carbamazepine administration.

Inventors

  • 👤 James A. Halikas

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 14:46
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 39 words
A method for reducing the use of psychostimulants and psychoactive compounds which cause kindling in animals, which method comprises orally administering to an animal in need an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim 39 words
A method for reducing the use of psychostimulants and psychoactive compounds which cause kindling in animals, which method comprises orally administering to an animal in need an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 43 words
The method of claim 1 wherein said psychostimulants and psychoactive compounds are selected from the group consisting of phencyclidine (PCP), lysergic acid diethylamide (LSD), methamphetamine, methylene dioxymethamphetamine (MDMA), amphetamine, D amphetamine, methylphenidate, DL phenylpropanolamine (PPA), Procaine, Lidocaine, Methedrine, Desoxyn, cocaine, freebase and Crack.
Claim 4
Independent Claim 38 words
A method for treating drug abuse in patients taking a drug which causes pharmacologically-induced kindling, which method comprises orally administering to a patient in need an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Independent Claim 38 words
A method for treating drug abuse in patients taking a drug which causes pharmacologically-induced kindling, which method comprises orally administering to a patient in need an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Independent Claim 33 words
A method for reducing the craving for cocaine in living animals in need thereof which method comprises orally administering thereto an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Independent Claim 33 words
A method for reducing the craving for cocaine in living animals in need thereof which method comprises orally administering thereto an effective amount of carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Independent Claim 39 words
A method for reducing the craving for cocaine in humans in need thereof which method includes the step of orally administering daily thereto between about 100 and about 1600 mg carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Independent Claim 39 words
A method for reducing the craving for cocaine in humans in need thereof which method includes the step of orally administering daily thereto between about 100 and about 1600 mg carbamazepine or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 43 words
The method of claim 5 wherein said human is initially given carbamazepine or a pharmaceutically acceptable acid addition salt thereof in a 100 to 200 mg dosage which progressively increases until craving is eliminated to a maximum of about 1600 mg per day.
Claim 11
Independent Claim 55 words
A method for treating cocaine addiction in man by reducing the craving for cocaine, the method including the step of ingesting carbamazepine or a pharmaceutically acceptable acid addition salt thereof in an initial 200 mg dosage followed by progressive increases until cocaine use is controlled, up to a maximum of about 1600 mg per day.
Claim 12
Independent Claim 55 words
A method for treating cocaine addiction in man by reducing the craving for cocaine, the method including the step of ingesting carbamazepine or a pharmaceutically acceptable acid addition salt thereof in an initial 200 mg dosage followed by progressive increases until cocaine use is controlled, up to a maximum of about 1600 mg per day.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-01 1994-12-31 1995-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-01 1998-12-31 1999-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-01 2002-12-31 2003-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag